ERBB2 and Wilson disease: As for miR‐146a‐3p, it is identified as an ERBB2 inhibitor, obstructing the differentiation of human adipose‐derived mesenchymal stem cells (hAMSCs) into Schwann‐like cells [30]; however, the detailed mechanisms of this miRNA’s interaction with neural cells in WD require further elucidation.